A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how ...

RAPTER aims to identify the most effective vaccine strategy to help protect the population from pandemics, such as the COVID-19 pandemic. Shown here, a PNNL researcher performs a test to detect the ...

Bacterial ghosts (BGs) represent an innovative platform that exploits empty Gram‐negative bacterial envelopes produced through controlled lysis. These envelopes retain the native antigenic ...

Essential tools for understanding viral evolution, monoclonal anitbodies guide therapeutic development and inform vaccine ...

Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...

Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...

Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.

"Vaccine development is usually measured in years and sometimes even decades," Adalja said. "And there are some infectious diseases for which we have no vaccine after decades and decades of work, like ...